Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 5:31 PM ET

Date/Time Source News Release
05/28/2025 08:30 AM EDT GlobeNewswire Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
05/20/2025 08:30 AM EDT GlobeNewswire Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake
05/13/2025 07:30 AM EDT GlobeNewswire Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program
05/06/2025 08:30 AM EDT GlobeNewswire Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
04/21/2025 11:19 AM EDT GlobeNewswire Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine
03/11/2025 07:30 AM EDT GlobeNewswire Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program
03/07/2025 08:30 AM EST GlobeNewswire Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference
03/06/2025 08:30 AM EST GlobeNewswire Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025
02/11/2025 08:30 AM EST GlobeNewswire Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference
02/10/2025 08:30 AM EST GlobeNewswire Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
Page

Additional News

As of June 12, 2025 • 5:31 PM ET

Date/Time Source News Release
06/03/2025 06:28 PM EDT SeekingAlpha Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk
05/13/2025 12:16 PM EDT SeekingAlpha Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones
05/13/2025 12:16 PM EDT SeekingAlpha Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript
05/13/2025 07:32 AM EDT SeekingAlpha Achieve Life Sciences GAAP EPS of -$0.37 in-line
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Achieve Life Sciences Inc.
05/12/2025 12:07 PM EDT SeekingAlpha Achieve Life Sciences Q1 2025 Earnings Preview
03/11/2025 02:52 PM EDT SeekingAlpha Achieve Life Sciences, Inc. (ACHV) Q4 2024 Earnings Call Transcript
03/11/2025 07:34 AM EDT SeekingAlpha Achieve Life Sciences GAAP EPS of -$0.36 misses by $0.03
03/11/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, March 11th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.